Welcome Dr. Fujii to the CNG!
Join us in welcoming Dr. Fujii to the Center!
Posted in
Recent News
CNG Graduate Student awarded research fellowship
Avery Englebrecht was awarded a Doctoral Research Fellowship in DM from the Myotonic Dystrophy Foundation.
CNG Graduate Student awarded NINDS research training grant
Eduardo (Eddy) Rijos' training program is designed to increase participation of underrepresented individuals and enhance the diversity of the research workforce.
Study shows diabetes drug improves symptoms in subtype of ALS in mice
Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.
Dr. Lien Nguyen awarded an NIH K99
The K99 will support research on developing tools to identify novel repeat expansion mutations and studying the role of these mutations in Alzheimer’s disease.
CNG Postdoc awarded Fellowship from the ALS Association
Dr. Lauren Laboissonniere was awarded 2-year $100,000 fellowship to investigate a potential vaccine therapy.
2020 MBI Award Winner Benjamin Kidd
Congratulations Benjamin Kidd on receiving an MBI Fellowship!
New preclinical study shows common diabetes drug improves symptoms in genetic form of ALS
A new study shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.
New study shows antibody therapy could offer treatment path for genetic form of ALS and FTD
Drs. Laura Ranum and Lien Nguyen Online version with high-res image available here: https://www.cell.com/neuron/fulltext/S0896-6273(19)30970-5 GAINESVILLE, Fla. — New preclinical research shows promise for a potential treatment pathway aimed at slowing the disease process and extending survival in patients with ALS, often called Lou Gehrig’s disease, an…
